Evidence map›Paper›PMID 34900838›Full record

ReviewJournal of diabetes and metabolic disorders2021

Contribution of Iranian researchers in Alzheimer's disease research: A 10 years scientometric analysis.

Arash Ghazbani, Mohammad Javad Mansourzadeh, Golbarg Mehdizadeh, Mojtaba Ghobadi, Seyed Masoud Arzaghi, Afshin Ostovar

Abstract readReview
In one paragraph

Review in Journal of diabetes and metabolic disorders, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Arash GhazbaniStudent Research Committee, Bushehr University of Medical Sciences, Bushehr, Iran.ORCID 0000-0002-5569-7330
Mohammad Javad MansourzadehSchool of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran.ORCID 0000-0002-0666-7928
Golbarg MehdizadehStudent Research Committee, Bushehr University of Medical Sciences, Bushehr, Iran.ORCID 0000-0003-1266-5133
Mojtaba GhobadiDepartment of Physiology, Shiraz University of Medical Sciences, Shiraz, Iran.ORCID 0000-0001-8629-4510
Seyed Masoud ArzaghiElderly Health Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.ORCID 0000-0002-1867-1596
Afshin OstovarOsteoporosis Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, No. 10, Jalal-Al-Ahmad Ave., Tehran, Iran.ORCID 0000-0001-8670-5797

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlzheimer's disease is the most common form of dementia and is a rising issue for global health. Iran is struggling with a growing number of the elderly population and also a decrease in fertility rate. The goal of this study was to review and evaluate Alzheimer's disease publications by Iranian researchers.

methodsWe searched for Alzheimer and all its related keywords in the

resultsTotally, 1042 documents from 4949 researchers (8.6 authors per document) were retrieved from

conclusionWe found that Iranian researchers made significant impacts in the field of Alzheimer's disease and covered a wide range of related areas over the last 10 years.

Indexed as

AlzheimerBibliometricsDementiaPublicationsScientometricsTauopathy

Identifiers

PMID34900838
PMCPMC8630238

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.